In BC patients treated with neoadjuvant chemotherapy, elevated nerve growth factor (NGF) within serum-derived sEVs was related to poor survival outcomes, suggesting NGF in sEVs was an independent prognostic factor for overall survival [156]. Here, NGF is linked to breast cancer.